标题
Cardiovascular outcome trials in obesity: A review
作者
关键词
-
出版物
Obesity Reviews
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-09-10
DOI
10.1111/obr.13112
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Treating obesity in patients with cardiovascular disease: the pharmacotherapeutic options
- (2019) Caroline A. Andrew et al. EXPERT OPINION ON PHARMACOTHERAPY
- Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications
- (2019) Michele Longo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study
- (2019) Qiuhong Gong et al. Lancet Diabetes & Endocrinology
- Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program
- (2019) Toshiaki Ohkuma et al. DIABETES OBESITY & METABOLISM
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2019) Søren L Kristensen et al. Lancet Diabetes & Endocrinology
- Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity
- (2018) Sadiya S. Khan et al. JAMA Cardiology
- Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
- (2018) Erin A. Bohula et al. NEW ENGLAND JOURNAL OF MEDICINE
- High cardiovascular risk patients benefit more from bariatric surgery than low cardiovascular risk patients
- (2018) David Gutierrez Blanco et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis
- (2017) Camille Lassale et al. EUROPEAN HEART JOURNAL
- 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
- (2017) Carel W le Roux et al. LANCET
- Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
- (2017) Philip R. Schauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms, Pathophysiology, and Management of Obesity
- (2017) Steven B. Heymsfield et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors
- (2016) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s
- (2016) Catherine E. Thomas et al. Obesity
- Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial
- (2016) Lancet Diabetes & Endocrinology
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials
- (2013) V. L. Gloy et al. BMJ-British Medical Journal
- Anti-obesity drugs: past, present and future
- (2012) R. J. Rodgers et al. Disease Models & Mechanisms
- Cardiovascular Risk Assessment in the Development of New Drugs for Obesity
- (2012) William R. Hiatt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bariatric Surgery and Long-term Cardiovascular Events
- (2012) Lars Sjöström et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial
- (2011) I. D. Caterson et al. DIABETES OBESITY & METABOLISM
- Effect of the Look AHEAD Study Intervention on Medication Use and Related Cost to Treat Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
- (2010) J. B. Redmon et al. DIABETES CARE
- Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial
- (2010) Eric J Topol et al. LANCET
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
- (2010) W. Philip T. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders
- (2009) David J. Heal et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A review and meta-analysis of the effect of weight loss on all-cause mortality risk
- (2009) Mary Harrington et al. NUTRITION RESEARCH REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now